Orchid Pharma Limited (NSE:ORCHPHARMA)

Orchid Pharma Revenue

Orchid Pharma had revenue of 3.04B INR in the quarter ending June 30, 2026, with 75.89% growth. This brings the company's total for the last twelve months to 8.52B, up 0.22% year-over-year. In the fiscal year ending March 31, 2026, Orchid Pharma had annual revenue of 12.33B, down -11.79%. That makes Orchid Pharma the 23,457th largest company in the world by revenue and 1,399th in India.

• Revenue (ttm): 8.52B
• Revenue Growth: +0.22%
• P/S Ratio: 5.21
• Revenue / Employee: 7.29M
• Employees: 1,169
• Market Cap: 42.64B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• Rest of the World 7.96B 65.7%
• India 4.15B 34.3%

Fiscal year ended Mar 31, 2026 See the full Orchid Pharma breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	12.33B	-1.65B	-11.79%
Mar 31, 2025	13.98B	5.78B	70.57%
Mar 31, 2024	8.19B	1.53B	23.05%
Mar 31, 2023	6.66B	1.06B	19.00%
Mar 31, 2022	5.60B	1.09B	24.33%

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 20, 2026

Data Sources Report a data error